找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Social Media: The Good, the Bad, and the Ugly; 15th IFIP WG 6.11 Co Yogesh K. Dwivedi,Matti M?ntym?ki,Antonis C. Simin Conference proceedin

[復(fù)制鏈接]
樓主: 冰凍
41#
發(fā)表于 2025-3-28 16:50:13 | 只看該作者
42#
發(fā)表于 2025-3-28 20:21:50 | 只看該作者
Ton A. M. Spil,Robin Effing,Menno P. Both and summarizes major current and emerging guideline considerations in the elderly population. First step agents include diuretics and calcium channel blockers with additional agents as needed (depending upon compelling indications), to lower blood pressure and decrease cardiovascular outcomes.
43#
發(fā)表于 2025-3-29 00:50:07 | 只看該作者
Shirumisha Kwayu,Banita Lal,Mumin Abubakreent Practice and the Application of Landmark Trials.?.is a critical tool to assist in the education of physicians and researchers in the field, providing a separate section on pioneer researchers in hypertension and urging readers to become bright exemplars for scientists wishing to pursue a career
44#
發(fā)表于 2025-3-29 05:31:32 | 只看該作者
Issam A. R. Moghrabi,Abdullah R. Al-Mohammedould be part of routine assessment of hypertensive patients. Subclinical organ damage should be also measured during treatment because there is evidence that regression of left ventricular hypertrophy and reduction of proteinuria are associated with improved prognosis. Search for subclinical organ d
45#
發(fā)表于 2025-3-29 09:40:06 | 只看該作者
Manoj Kumar Singh,Harish Kumar,M. P. Gupta,J. Madaanct. In spite of apparent advantages of the out-of-office blood pressure measurement, either ambulatory or home blood pressure monitoring, it was only used in a subset of study participants of few trials in hypertension, and its superiority over office blood pressure in guiding antihypertensive thera
46#
發(fā)表于 2025-3-29 13:49:03 | 只看該作者
47#
發(fā)表于 2025-3-29 17:16:06 | 只看該作者
48#
發(fā)表于 2025-3-29 22:01:16 | 只看該作者
49#
發(fā)表于 2025-3-30 01:38:45 | 只看該作者
50#
發(fā)表于 2025-3-30 05:54:11 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 14:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
通道| 金昌市| 云林县| 和硕县| 高邮市| 静乐县| 呼和浩特市| 金山区| 四会市| 玉田县| 新竹市| 陇川县| 栾川县| 宜黄县| 拉萨市| 吉林省| 衡阳市| 裕民县| 盖州市| 高要市| 巨野县| 新营市| 乌兰县| 滨海县| 拜泉县| 玉环县| 嘉禾县| 榕江县| 洛扎县| 陆良县| 古交市| 乡宁县| 凌海市| 黑河市| 如东县| 通河县| 印江| 清水河县| 云和县| 宣化县| 乐东|